Federal report finds foreseeable, disproportionate COVID-19 fatalities, heavy toll for people with disabilities

NEXT STORY
Skylight Health Group Executes Definitive Asset Purchase Agreement to Divest Legacy Business to New Frontier Data
PREV STORY
Global Intravascular Ultrasound (IVUS) Market to Reach $849.6 Million by 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Summit Announces Further US Patent Granted for CDI Antibiotic Ridinilazole

OXFORD, United Kingdom, April 28, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), ...

author_avatar
NASDAQ Market News

Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer

author_avatar
NASDAQ Market News

Summit Therapeutics to Participate in 2018 BTIG Healthcare Conference

OXFORD, United Kingdom, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), ...

author_avatar
NASDAQ Market News